ARCHIVES

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

ACD Honors Sullivan, Who Reaffirms Anti-Smoking Effort

June 29, 1990

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006

NCI Plans To Issue Frederick Operations Contract As Sole-Source To SAIC-Frederick Inc. For Up To 10 Years.

November 10, 2006

Appropriations 2013: Obama Proposes Flat Funding for NIH

February 17, 2012

Michelle Le Beau named director of University of Chicago Cancer Research Center.

May 7, 2004

NCI Sets its Targets for Grant Success Rate and R01 Payline for FY05.

January 21, 2005